Όλο το DSpace

Πλοήγηση ανά Θέμα "cancer screening"

Αποτελέσματα 1-11 από 11

    • Acceptability of Self-Sampling for Human Papillomavirus-Based Cervical Cancer Screening 

      Chatzistamatiou K., Vrekoussis T., Tsertanidou A., Moysiadis T., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moschaki V., Ntoula M., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Daponte A., Vanakara P., Paschopoulos M., Stefos T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Deligeoroglou E., Panoskaltsis T., Adonakis G., Michail G., Stamatopoulos K., Agorastos T. (2020)
      Background: Human papillomavirus (HPV)-DNA testing combined with self-sampling could increase cervical cancer screening effectiveness, utilizing a sensitive screening modality and an easy sampling method with minimal pain ...

    • The future of capsule endoscopy in clinical practice: From diagnostic to therapeutic experimental prototype capsules 

      Vasilakakis M.D., Koulaouzidis A., Marlicz W., Iakovidis D.K. (2020)
      Capsule endoscopy (CE) is indicated as a first-line clinical examination for the detection of small-bowel pathology, and there is an ever-growing drive for it to become a method for the screening of the entire gastrointestinal ...

    • Implementation of HPV-based Cervical Cancer Screening Combined with Self-sampling Using a Midwifery Network across Rural Greece: The Grecoself study 

      Agorastos T., Chatzistamatiou K., Tsertanidou A., Mouchtaropoulou E., Pasentsis K., Kitsou A., Moysiadis T., Moschaki V., Skenderi A., Katsiki E., Aggelidou S., Venizelos I., Ntoula M., Daponte A., Vanakara P., Garas A., Stefos T., Vrekoussis T., Lymberis V., Kontomanolis E.N., Makrigiannakis A., Manidakis G., Deligeoroglou E., Panoskaltsis T., Decavalas G.O., Michail G., Kalogiannidis I., Koukoulis G., Zempili P., Halatsi D., Truva T., Piha V., Agelena G., Chronopoulou A., Vaitsi V., Chatzaki E., Paschopoulos M., Adonakis G., Kaufmann A.M., Hadzidimitriou A., Stamatopoulos K. (2019)
      Self-sampling for human papillomavirus (HPV) testing is an alternative to physician sampling particularly for cervical cancer screening nonattenders. The GRECOSELF study is a nationwide observational cross-sectional study ...

    • Machine learning for rhabdomyosarcoma histopathology 

      Frankel A.O., Lathara M., Shaw C.Y., Wogmon O., Jackson J.M., Clark M.M., Eshraghi N., Keenen S.E., Woods A.D., Purohit R., Ishi Y., Moran N., Eguchi M., Ahmed F.U.A., Khan S., Ioannou M., Perivoliotis K., Li P., Zhou H., Alkhaledi A., Davis E.J., Galipeau D., Randall R.L., Wozniak A., Schoffski P., Lee C.-J., Huang P.H., Jones R.L., Rubin B.P., Darrow M., Srinivasa G., Rudzinski E.R., Chen S., Berlow N.E., Keller C. (2022)
      Correctly diagnosing a rare childhood cancer such as sarcoma can be critical to assigning the correct treatment regimen. With a finite number of pathologists worldwide specializing in pediatric/young adult sarcoma ...

    • Prevention and screening for colorectal cancer 

      Tsakiridou, I.; Argyriou, K.; Hatzitolios, A. (2010)
      Colorectal cancer is one of the most common cancers worldwide. It is related to adoption of the western way of life and in the majority of cases, excluding the hereditary type, it appears to be more common in elderly people. ...

    • Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology 

      Agorastos, T.; Chatzistamatiou, K.; Katsamagkas, T.; Koliopoulos, G.; Daponte, A.; Constantinidis, T.; Constantinidis, T. C. (2015)
      Objectives The objective of the present study is to assess the performance of a high-risk human papillomavirus (HR-HPV) DNA test with individual HPV-16/HPV-18 genotyping as a method for primary cervical cancer screening ...

    • Prostate cancer: ESMO consensus conference guidelines 2012 

      Horwich, A.; Hugosson, J.; de reijke, T.; Wiegel, T.; Fizazi, K.; Kataja, V.; Parker, C.; Bellmunt, J.; Berthold, D.; Bill-axelson, A.; Carlsson, S.; Daugaard, G.; De meerleer, G.; De reijke, T.; Dearnaley, D.; Fonteyne, V.; Gillessen, S.; Heinrich, D.; Kwiatkowski, M.; Nilsson, S.; Padhani, A.; Papandreou, C.; Roobol, M.; Sella, A.; Valdagni, R.; Van der kwast, T.; Verhagen, P. (2013)
      The first ESMO Consensus Conference on prostate cancer was held in Zurich, Switzerland, on 17-19 November 2011, with the participation of a multidisciplinary panel of leading professionals including experts in methodological ...

    • Prostate Cancer: Quo Vadis? 

      Logothetis C.J., Aparicio A., Koinis F., Corn P.G., Efstathiou E. (2019)
      Utility measures are urgently needed for clinical application of new, more sensitive diagnostics to reduce the risk of excessive intervention. © 2019 European Association of Urology

    • Screening for renal cell carcinoma in dialysis patients 

      Liakopoulos V., Eleftheriadis T., Mertens P.R. (2018)
      [No abstract available]

    • Self-sampling for high-risk human papillomavirus detection: Future cervical cancer screening? 

      Daponte, A.; Pournaras, S.; Tsakris, A. (2014)

    • Survivin autoantibodies are not elevated in lung cancer when assayed controlling for specificity and smoking status 

      Broodman I., VanDuijn M.M., Stingl C., Dekker L.J.M., Germenis A.E., De Koning H.J., Van Klaveren R.J., Aerts J.G., Lindemans J., Luider T.M. (2016)
      The high mortality rate in lung cancer is largely attributable to late diagnosis. Case-control studies suggest that autoantibodies to the survivin protein are potential biomarkers for early diagnosis. We tested the hypothesis ...